ARTICLE | Company News
Glaxo Wellcome other research news
January 8, 2001 8:00 AM UTC
GLXO, now GlaxoSmithKline plc (LSE:GSK; GSK), reported in Science the structure-based design of inhibitors to CDK-2, a kinase that plays a role in cellular proliferation, and their use to prevent che...